Francesca Barone Candel Therapeutics, Inc. (CADL) insider trading activity
Francesca Barone is Chief Scientific Officer of Candel Therapeutics, Inc.. Currently has a direct ownership of 137,880 shares of CADL, which is worth approximately $1.1 Million. The most recent transaction as insider was on Nov 29, 2024, when has been sold 22,081 shares (Common Stock) at a price of $4.56 per share, resulting in proceeds of $100,689. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
138K
13.8%
3M change
26.13%
12M change
Total Value Held
$1.1 Million
Francesca Barone Transaction History
FB
Francesca Barone
Chief Scientific Officer
Needham, MA